Ayurveda pharmacovigilance is becoming essential for patients using Ayurvedic medicines alongside diabetes, heart, cancer, autoimmune or other chronic disease treatments. India’s renewed safety focus highlights herb–drug interactions, adverse reactions, herbo-mineral medicine quality and the need for evidence-backed monitoring.

WHO’s 2025–2034 traditional medicine research agenda could reshape how Ayurveda is studied, regulated and integrated into healthcare. This patient-focused guide explains the evidence gap, safety priorities, India’s research role and what the WHO roadmap means when choosing responsible, evidence-informed Ayurvedic care.